← back to search

Lena Specht

IT University of Copenhagen · DK
Area of research
Pathology and Forensic Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Head and Neck Cancer Studies, Advanced Radiotherapy Techniques, and Lung Cancer Treatments and Mutations.
h-index
72
citations
26,649
works
587
NIH funding
primary concept
Medicine
email

Recent publications

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.
2026cited by 0position: contributordoi
Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy.
2026cited by 0position: contributordoi
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
2026cited by 0position: contributordoi
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members.
2025cited by 6position: contributordoi
Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024.
2025cited by 5position: contributordoi
Late Cardiac Toxicity After Anthracyclines and Radiotherapy for Lymphoma-A Regression Analysis of Dose-Response.
2025cited by 2position: contributordoi
Risk Stratification for Trial Enrichment Considering Loco-Regional Failure in Head and Neck Cancer: UICC8 Versus Purpose-Built Failure-Type Specific Risk Prediction Model.
2025cited by 2position: contributordoi
Total skin electron beam therapy.
2025cited by 0position: contributordoi
Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report.
2025cited by 0position: contributordoi
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
2024cited by 33position: contributordoi
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
2024cited by 20position: contributordoi
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Journal of Clinical Oncology 2024cited by 17position: middledoi
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
2024cited by 15position: contributordoi
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
2024cited by 12position: contributordoi
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members
International Journal of Radiation Oncology*Biology*Physics 2024cited by 7position: middledoi
Personalised therapy in follicular lymphoma - is the dial turning?
2024cited by 5position: contributordoi
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma.
2024cited by 2position: contributordoi
Evolution, and current and future role of radiotherapy in the treatment of haematological malignancies.
2024cited by 2position: contributordoi
Career development: A balance of opportunities and choices.
2024cited by 2position: contributordoi
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.
2024cited by 2position: contributordoi
Late effects following HSCT for childhood ALL: A national single-center study using three different modalities of delivery of total body irradiation.
2024cited by 0position: contributordoi
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
2023cited by 40position: contributordoi
Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality.
2023cited by 14position: contributordoi
A systematic review on clinical adaptive radiotherapy for head and neck cancer.
2023cited by 9position: contributordoi
Reappraisal of the role of radiation therapy in lymphoma treatment.
2023cited by 7position: contributordoi
A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned.
2023cited by 3position: contributordoi
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes.
2023cited by 2position: contributordoi
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis.
2023cited by 2position: contributordoi
THE PROGNOSTIC IMPACT OF CLINICAL FACTORS AND IMMUNOARCHITECTURAL PATTERNS FOR NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA: AN INTERNATIONAL STUDY BY GLOW
Hematological Oncology 2023cited by 1position: middledoi
Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours.
2023cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 33 papers (2019–2026)Christian von Buchwald · Institute of Clinical Research15 papers (2019–2023)Ivan R. Vogelius · University of Maryland, Baltimore13 papers (2019–2026)Søren M. Bentzen · University Hospitals of Cleveland8 papers (2019–2021)Jens Lundgren · Aalborg University7 papers (2019–2023)Marie Helleberg · University of Copenhagen7 papers (2019–2023) · 7 papers (2019–2026)Tim Illidge · Manchester Academic Health Science Centre7 papers (2013–2020)Charlotte Duch Lynggaard · Rigshospitalet6 papers (2022–2023)Joachim Yahalom · Cornell University6 papers (2013–2020)N. George Mikhaeel · Guy's and St Thomas' NHS Foundation Trust6 papers (2013–2021)Helene Stampe · Copenhagen University Hospital5 papers (2022–2023) · 5 papers (2022–2023)Urszula M. Ciochon · Copenhagen University Hospital5 papers (2022–2023)Tobias T. Andersen · University of Copenhagen5 papers (2022–2023)Andreas Kjær · University Hospital of Bern5 papers (2019–2021)Adam E. Hansen · Københavns Universitet5 papers (2022–2023) · 5 papers (2022–2023)Martin Hutchings · European Organisation for Research and Treatment of Cancer5 papers (2014–2026)Richard T. Hoppe · Stanford Medicine5 papers (2013–2025)